TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/20/25 21:49 | 3/18/25 | TARS | Tarsus Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wahl Bryan | CA | O | GC | S.m | -464 | 47.88 | 0 | -10 | -16 | 52 | D | ||||||||||||||
3/19/24 19:05 | 3/18/24 | TARS | Tarsus Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wahl Bryan | CA | O | GC | S.d | -136 | 30.60 | 0 | -4 | -10 | 41 | D | ||||||||||||||
12/1/23 16:55 | 11/30/23 | TARS | Tarsus Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wahl Bryan | CA | O | GC | S.d | -136 | 16.31 | 0 | -8 | -21 | 32 | D | ||||||||||||||
3/23/23 19:52 | 3/21/23 | TARS | Tarsus Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wahl Bryan | CA | O | GC | S.m | -14 | 12.55 | 0 | -1 | -6 | 16 | D | ||||||||||||||
3/21/23 19:14 | 3/17/23 | TARS | Tarsus Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wahl Bryan | CA | O | GC | S.m | -9 | 12.94 | 0 | -1 | -4 | 17 | D | ||||||||||||||
3/17/23 18:21 | 3/16/23 | TARS | Tarsus Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wahl Bryan | CA | O | GC | S.d | -5 | 13.43 | 0 | 0 | -2 | 18 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |